- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: olaparib
Total 430 results
-
AstraZenecaCompletedPlatinum Refractory Extensive-Stage Small Cell Lung CarcinomaSpain, Poland, Hungary, Ukraine, Germany
-
AstraZenecaCompletedAdvanced Solid TumorsUnited States, Spain
-
Merck Sharp & Dohme LLCActive, not recruitingSolid TumorsPoland, Korea, Republic of, United States, Argentina, Australia, Canada, Colombia, France, Germany, Guatemala, Israel, Italy, Japan, Latvia, Mexico, Peru, Puerto Rico, Romania, South Africa, Spain, Sweden, Turkey, Ukraine
-
University of WashingtonAstraZenecaTerminatedCastration-Resistant Prostate Carcinoma | Prostate AdenocarcinomaUnited States
-
Merck Sharp & Dohme LLCGynecologic Oncology Group; European Network of Gynaecological Oncological...Active, not recruitingPeritoneal Neoplasms | Ovarian Cancer | Fallopian Tube CancerPoland, Korea, Republic of, United States, Australia, Belgium, Brazil, Canada, Chile, Colombia, Czechia, France, Germany, Hungary, Israel, Italy, Japan, Russian Federation, South Africa, Spain, Taiwan, Turkey, Ukraine
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | Acute Myeloid Leukemia Post Cytotoxic TherapyUnited States
-
AstraZenecaCompletedOvarian Cancer, Hereditary Ovarian Cancer SyndromeGermany
-
AstraZenecaMerck Sharp & Dohme LLCCompletedAdvanced Ovarian CancerUnited States
-
Matthew GalskyIcahn School of Medicine at Mount Sinai; AstraZenecaCompletedMetastatic Urothelial CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingMantle Cell LymphomaUnited States
-
Hoffmann-La RocheFoundation Medicine, Inc.Active, not recruitingCancer of Unknown Primary SiteUnited Kingdom, Korea, Republic of, France, Australia, Germany, Austria, Croatia, Denmark, Finland, Greece, Hungary, Italy, Portugal, Spain, Japan, Brazil, Colombia, Mexico, Romania, Czechia, Norway, Thailand, Switzerland, Turkey, Nethe... and more
-
Washington University School of MedicineMerck Sharp & Dohme LLC; Joseph Sanchez FoundationActive, not recruitingRecurrent Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck Squamous Cell CarcinomaUnited States
-
Vastra Gotaland RegionAdvanced Accelerator ApplicationsActive, not recruitingThymoma | Neuroendocrine Tumors | Mesothelioma | Clinical Trial, Phase ISweden
-
AstraZenecaMerck Sharp & Dohme LLCCompletedMetastatic Castration-resistant Prostate CancerBelgium, France, Italy, Netherlands, Poland, United States, Canada, Czechia, Russian Federation, United Kingdom, Spain
-
National Cancer Institute (NCI)Active, not recruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Adenocarcinoma AJCC v7 | Advanced Prostate Adenocarcinoma With Neuroendocrine Differentiation | Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation | Prostate Adenocarcinoma With Neuroendocrine...United States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
The Netherlands Cancer InstituteAstraZenecaActive, not recruitingHead and Neck Neoplasms | Carcinoma, Squamous Cell | Laryngeal Cancer Stage II | Laryngeal Cancer Stage IIINetherlands
-
ARCAGY/ GINECO GROUPActive, not recruiting
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLC; AstraZenecaActive, not recruitingProstate Carcinoma | Prostate Cancer AggressivenessUnited States
-
AstraZenecaCompletedType 2 Diabetes MellitusSweden
-
National Cancer Institute (NCI)TerminatedExtensive Stage Lung Small Cell CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Renal Cell Carcinoma | Metastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Metastatic Melanoma | Fallopian Tube Carcinoma | Advanced Malignant Solid Neoplasm | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage III Renal... and other conditionsUnited States
-
AstraZenecaActive, not recruitingOvary CancerFrance, United Kingdom
-
Helwan UniversityCompleted
-
Abramson Cancer Center at Penn MedicineActive, not recruitingAdvanced Breast Cancer | Metastatic Breast Cancer | BRCA1 Mutation | BRCA2 Mutation | Locally Advanced Breast CancerUnited States
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetics, Inc.; Foundation Medicine, Inc.CompletedMetastatic Castration-resistant Prostate CancerUnited States, Canada, Denmark, Germany, Italy, Netherlands, Norway, Spain, Argentina, Taiwan, France, Korea, Republic of, Brazil, Japan, Turkey, United Kingdom, Austria, Australia, Israel, Sweden
-
University Hospitals Cleveland Medical CenterActive, not recruitingPost-acute COVID-19 SyndromeUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...AstraZenecaActive, not recruiting
-
National Cancer Institute (NCI)NRG OncologyWithdrawnRecurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Recurrent Fallopian Tube Endometrioid Adenocarcinoma | Recurrent Ovarian Endometrioid Adenocarcinoma | Recurrent Platinum-Resistant Fallopian Tube Carcinoma | Recurrent Platinum-Resistant Primary... and other conditionsUnited States
-
Italian Sarcoma GroupAstraZeneca; PharmaMarActive, not recruitingAdvanced Soft Tissue SarcomaItaly
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.CompletedMetastatic Adenocarcinoma of the Pancreas | Germline BRCA1/2 Mutations andUnited States, France, Italy, Spain, United Kingdom, Belgium, Canada, Germany, Korea, Republic of, Australia, Israel, Netherlands
-
AstraZenecaActive, not recruitingRelapsed Ovarian Cancer | Following Complete or Partial Response to Platinum Based Chemotherapy | Platinum SensitiveChina, Malaysia
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Non-squamous Non-small-cell LungPoland, Korea, Republic of, Ukraine, United States, Argentina, Australia, Austria, Canada, France, Japan, New Zealand, Romania, Russian Federation, Taiwan, Turkey, United Kingdom, Brazil, Colombia, Germany, Spain
-
ARCAGY/ GINECO GROUPAstraZenecaCompletedRelapsed Ovarian Cancers PatientsFrance
-
Yale UniversityCompleted
-
University of Michigan Rogel Cancer CenterAstraZeneca; Janssen Scientific Affairs, LLCActive, not recruitingSarcoma | Sarcoma MetastaticUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); AstraZenecaActive, not recruitingMetastatic Prostate Carcinoma | Stage IV Prostate Cancer | Prostate Cancer Metastatic Castration-Resistant | Abnormal DNA RepairUnited States
-
NCIC Clinical Trials GroupAstraZenecaCompletedColorectal CancerCanada
-
Ellipses PharmaCompletedOvarian CancerUnited States, United Kingdom, Hungary
-
AstraZenecaCompletedGastric CancerKorea, Republic of
-
AstraZenecaBritish Columbia Cancer AgencyCompleted
-
SandozCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); AstraZenecaCompletedPancreatic Ductal Adenocarcinoma | Metastatic Pancreatic Adenocarcinoma | Stage IV Pancreatic Cancer AJCC v6 and v7United States
-
National Cancer Center Hospital EastMerck Sharp & Dohme LLCCompleted
-
University of Michigan Rogel Cancer CenterActive, not recruitingProstate CancerUnited States
-
Sarah E TaylorAmerican Society of Clinical OncologyTerminatedOvarian CancerUnited States
-
First Affiliated Hospital Xi'an Jiaotong UniversityEnrolling by invitation
-
Ellipses PharmaWithdrawnGastric Cancer | Small-cell Lung CancerChina, Korea, Republic of, Taiwan
-
University Hospital, CaenCompleted
-
Qilu Pharmaceutical Co., Ltd.Completed